http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009060935-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12047d2ea67da864d583398b7017c1f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34f8db0be2e9af6d6d4b8c839d3a5bfd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
filingDate 2008-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0397859d1eda8662d0ca912b35214b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0358779e7cc9c89c21b63c67956dae4f
publicationDate 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009060935-A1
titleOfInvention Amebiasis vaccine
abstract An isolated protein fragment containing an epitope which is specific for E. histolytica and is commonly shared by all polymorphic strains of E. histolytica is provided, and which exhibits immunogenicity in the host, and comprises an amino acid sequence containing amino acid sequence 603-1088 of SEQ ID NO: 2, and in particular, consists of the amino acid sequence 603-1088. An isolated DNA coding for such fragment, a vector containing such DNA, a host cell, a vaccine for amebiasis containing such fragment having a low molecular weight which can be stably produced in the host cell or E. coli in a large amount and at a high production efficiency, a method for producing such vaccine, an antibody against such fragment, and a method for preventing or treating amebiasis by administering such fragment are also provided.
priorityDate 2007-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128571534
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5759
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5759
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451186576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10036
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57455154

Total number of triples: 51.